1. Home
  2. CMU vs APLT Comparison

CMU vs APLT Comparison

Compare CMU & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFS Municipal Income Trust

CMU

MFS Municipal Income Trust

HOLD

Current Price

$3.50

Market Cap

88.5M

Sector

Finance

ML Signal

HOLD

Logo Applied Therapeutics Inc.

APLT

Applied Therapeutics Inc.

HOLD

Current Price

$0.13

Market Cap

38.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMU
APLT
Founded
1987
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.5M
38.1M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CMU
APLT
Price
$3.50
$0.13
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$1.25
AVG Volume (30 Days)
82.4K
8.7M
Earning Date
01-01-0001
11-13-2025
Dividend Yield
4.08%
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
N/A
$1,000,000.00
Revenue This Year
N/A
$124.18
Revenue Next Year
N/A
$66.67
P/E Ratio
$47.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.78
$0.10
52 Week High
$3.38
$1.50

Technical Indicators

Market Signals
Indicator
CMU
APLT
Relative Strength Index (RSI) 52.37 27.50
Support Level $3.45 $0.10
Resistance Level $3.53 $0.13
Average True Range (ATR) 0.02 0.02
MACD 0.00 0.02
Stochastic Oscillator 90.20 18.92

Price Performance

Historical Comparison
CMU
APLT

About CMU MFS Municipal Income Trust

Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company invest various top Healthcare companies, Airport, Universities (Secondary Schools), Universities (Dormitories), and many more, out of maximum revenue is gained from Healthcare Hospitals and Long Term Care.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: